Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Cellular, Tissue and Gene Therapies Advisory Committee
February 9 - 10, 2006
Jeffrey S. Chamberlain, Ph.D.
Kenneth Cornetta, M.D.
James J. Mule, Ph.D.
Richard C. Mulligan, M.D.
Richard O. Snyder, Ph.D.
Anastasio Tsiatis, Ph.D.
January 25, 2006